https://www.selleckchem.com/products/bptes.html
0 vs. 2.7%; P less then 0.001) and primary anastomosis (88.0 vs. 51.4%; P=0.003), a greater number of dissected lymph nodes (30 vs. 18; P=0.001), and lower incidences of stoma formation (24.0 vs. 67.6%; P=0.002) and overall adverse events (24.0 vs. 62.2%; P=0.004). The 30-day mortality and disease-free survival of the SEMS group were not significantly different to that of the ES group (0 vs. 2.7%; P=1.000; log-rank test; P=0.1. In conclusion, as long as adverse events such as perforation are minimized, SEMS placement as a BTS could be a
Like
Comment
Share
